Sunshield Chemicals' board has approved a fresh plan to raise up to Rs. 150 crore through a Rights Issue of equity shares.

This new approval supersedes previous rights issue plans from August and September 2024, which have now been withdrawn.

The company clarifies this is not an additional offer but a renewed approval for the fundraise.

A Rights Issue Committee is authorized to finalize all terms, including pricing and ratio, subject to necessary approvals.

This move aims to raise capital and offers existing eligible shareholders an opportunity to participate.